Rajlok Diagnostic Systems Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 20-05-2024
- Paid Up Capital ₹ 8.60 M
as on 20-05-2024
- Company Age 25 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 3498.53%
(FY 2022)
- Profit 139.82%
(FY 2022)
- Ebitda 412.49%
(FY 2022)
- Net Worth 2.71%
(FY 2022)
- Total Assets 2.11%
(FY 2022)
About Rajlok Diagnostic Systems
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.60 M, as per Ministry of Corporate Affairs (MCA) records.
Lalchand Hotwani, Hardik Dhebar, Rakesh Prashad, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231DL1999PTC099912
- Company No.
099912
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 1999
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rajlok Diagnostic Systems?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalchand Hotwani  | Director | 01-Sep-2015 | Current |
| Hardik Dhebar | Additional Director | 26-Dec-2023 | Current |
| Rakesh Prashad | Director | 18-Apr-2019 | Current |
| Gajendra Nahar | Director | 01-Sep-2015 | Current |
Financial Performance of Rajlok Diagnostic Systems.
Rajlok Diagnostic Systems Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 3498.53% increase. The company also saw a substantial improvement in profitability, with a 139.82% increase in profit. The company's net worth moved up by a moderate rise of 2.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rajlok Diagnostic Systems?
In 2021, Rajlok Diagnostic Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Welspun Advanced Materials (India) LimitedActive 5 years 19 days
Lalchand Hotwani is a mutual person
- Welspun Realty Private LimitedActive 17 years 9 months
Lalchand Hotwani and Hardik Dhebar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rajlok Diagnostic Systems?
Unlock and access historical data on people associated with Rajlok Diagnostic Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajlok Diagnostic Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajlok Diagnostic Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
